[HTML][HTML] MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network

GB Migliori, S Tiberi, A Zumla, E Petersen… - International Journal of …, 2020 - Elsevier
The continuous flow of new research articles on MDR-TB diagnosis, treatment, prevention
and rehabilitation requires frequent update of existing guidelines. This review is aimed at …

Integrating pharmacokinetics and pharmacodynamics in operational research to end tuberculosis

JWC Alffenaar, T Gumbo, KE Dooley… - Clinical Infectious …, 2020 - academic.oup.com
Tuberculosis (TB) elimination requires innovative approaches. The new Global Tuberculosis
Network (GTN) aims to conduct research on key unmet therapeutic and diagnostic needs in …

Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases

M Tadolini, LR Codecasa… - European …, 2020 - Eur Respiratory Soc
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19)
pandemic has attracted interest because of its global rapid spread, clinical severity, high …

[HTML][HTML] Gauging the impact of the COVID-19 pandemic on tuberculosis services: a global study

GB Migliori, PM Thong, JW Alffenaar… - European …, 2021 - Eur Respiratory Soc
The effects of the coronavirus disease 2019 (COVID-19) pandemic on tuberculosis (TB)
disease and TB services emerged in the beginning of 2020 [1, 2]. Epidemiological and …

[HTML][HTML] Worldwide effects of coronavirus disease pandemic on tuberculosis services, January–April 2020

GB Migliori, PM Thong, O Akkerman… - Emerging infectious …, 2020 - ncbi.nlm.nih.gov
Coronavirus disease has disrupted tuberculosis services globally. Data from 33 centers in
16 countries on 5 continents showed that attendance at tuberculosis centers was lower …

[HTML][HTML] Tuberculosis, COVID-19 and migrants: preliminary analysis of deaths occurring in 69 patients from two cohorts

I Motta, R Centis, L D'Ambrosio, JM García-García… - Pulmonology, 2020 - Elsevier
Little is known about the relationship between the COVID-19 and tuberculosis (TB). The aim
of this study is to describe a group of patients who died with TB (active disease or sequelae) …

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report

S Borisov, E Danila, A Maryandyshev… - European …, 2019 - Eur Respiratory Soc
The World Health Organization (WHO) recommends that countries implement
pharmacovigilance and collect information on active drug safety monitoring (aDSM) and …

[HTML][HTML] Global trends in the incidence rates of MDR and XDR tuberculosis: Findings from the global burden of disease study 2019

Q Bu, R Qiang, L Fang, X Peng, H Zhang… - Frontiers in …, 2023 - frontiersin.org
Purpose: The study aimed to quantify the global trends of the incidence rates of multidrug-
resistant (MDR) tuberculosis (MDR-TB) and extensively drug-resistant (XDR) tuberculosis …

Therapeutic drug monitoring in patients with tuberculosis and concurrent medical problems

AG Märtson, G Burch, S Ghimire… - Expert Opinion on …, 2021 - Taylor & Francis
Introduction Therapeutic drug monitoring (TDM) has been recommended for treatment
optimization in tuberculosis (TB) but is only is used in certain countries eg USA, Germany …

Acquisition of cross-resistance to bedaquiline and clofazimine following treatment for tuberculosis in Pakistan

A Ghodousi, AH Rizvi, AQ Baloch… - Antimicrobial agents …, 2019 - Am Soc Microbiol
We report on the first six cases of acquired resistance to bedaquiline in Pakistan. Seventy
sequential isolates from 30 drug-resistant-tuberculosis patients on bedaquiline-containing …